Nitroglicerina PH&T

Nitroglicerina PH&T may be available in the countries listed below.

Ingredient matches for Nitroglicerina PH&T

Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitroglicerina PH&T in the following countries:

• Italy

International Drug Name Search

Fluconazol Copyfarm

Fluconazol Copyfarm may be available in the countries listed below.

Ingredient matches for Fluconazol Copyfarm

Fluconazole

Fluconazole is reported as an ingredient of Fluconazol Copyfarm in the following countries:

• Denmark


• Sweden

International Drug Name Search

Cabergolin AL

Cabergolin AL may be available in the countries listed below.

Ingredient matches for Cabergolin AL

Cabergoline

Cabergoline is reported as an ingredient of Cabergolin AL in the following countries:

• Germany

International Drug Name Search

Recessan

Recessan may be available in the countries listed below.

Ingredient matches for Recessan

Lauromacrogol 400

Lauromacrogol 400 is reported as an ingredient of Recessan in the following countries:

• Germany

International Drug Name Search

Nosatel

Nosatel may be available in the countries listed below.

Ingredient matches for Nosatel

Dexketoprofen

Dexketoprofen tromethamine (a derivative of Dexketoprofen) is reported as an ingredient of Nosatel in the following countries:

• Greece

International Drug Name Search

Opana ER Extended-Release Tablets

Pronunciation: OX-i-MOR-fone
Generic Name: Oxymorphone
Brand Name: Opana ER

Opana ER Extended-Release Tablets are used to treat constant (around-the-clock), moderate to severe pain that is expected to last for an extended amount of time. Opana ER Extended-Release Tablets are not for patients who only need occasional or "as-needed" pain relief.

Opana ER Extended-Release Tablets must be swallowed whole. Do NOT break, crush, dissolve, or chew Opana ER Extended-Release Tablets before swallowing it. Do not drink alcohol or take medicines that contain alcohol while you are using Opana ER Extended-Release Tablets. Doing any of these things may cause Opana ER Extended-Release Tablets to be absorbed into the body too quickly. This could result in very serious side effects, including severe trouble breathing and death from overdose. If you are unsure if any of your medicines contain alcohol, check with your doctor or pharmacist.

Opana ER Extended-Release Tablets are used for:

Treating pain in adults with constant (around-the-clock), moderate to severe pain that is expected to last for an extended period of time. Opana ER Extended-Release Tablets are not for use right after surgery if you have not already been using narcotic pain relievers, or if the pain is mild or not expected to last for an extended period of time.

Opana ER Extended-Release Tablets are an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.

Do NOT use Opana ER Extended-Release Tablets if:

• you are allergic to any ingredient in Opana ER Extended-Release Tablets or any other codeine- or morphine-related medicine (eg, morphine, codeine, oxycodone)


• you have difficult or slowed breathing, high levels of carbon dioxide in the blood, or severe asthma, or you are having an asthma attack


• you are in labor


• you have moderate to severe liver problems


• you have severe diarrhea, bowel problems caused by antibiotics or food poisoning, or certain other severe bowel problems (eg, paralytic ileus)


• you are taking sodium oxybate (GHB) or an agonist/antagonist analgesic (eg, pentazocine)

Contact your doctor or health care provider right away if any of these apply to you.

Before using Opana ER Extended-Release Tablets:

Some medical conditions may interact with Opana ER Extended-Release Tablets. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have a history of lung or breathing problems (eg, asthma, emphysema, bronchitis, chronic obstructive pulmonary disease [COPD]), sleep apnea (you stop breathing when you sleep), curvature of the spine (eg, kyphoscoliosis), heart problems (eg, cor pulmonale), low blood pressure, dehydration, or low blood volume


• if you have severe drowsiness, a recent head injury, growths in the brain, increased pressure in the brain, or a history of seizures (eg, epilepsy)


• if you have liver or kidney problems, gallbladder or pancreas problems, adrenal gland problems (eg, Addison disease), an underactive thyroid, an enlarged prostate, a urinary blockage, or stomach or bowel problems (eg, inflammation), or if you have had recent stomach or bowel surgery.


• if you drink alcohol regularly, have symptoms of alcohol withdrawal, or have a history of suicidal thoughts or attempts


• if you have a personal or family history of mental or mood problems, alcohol abuse, or other substance abuse or dependence


• if you are in poor health or shock, are very overweight, or will be having surgery

Some MEDICINES MAY INTERACT with Opana ER Extended-Release Tablets. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Phenothiazines (eg, chlorpromazine) because the risk of low blood pressure may be increased


• Barbiturate anesthetics (eg, thiopental), cimetidine, or sodium oxybate (GHB) because the risk of severe drowsiness, coma, confusion, or slowed or difficult breathing may be increased


• Anticholinergics (eg, scopolamine, benztropine) because the risk of severe constipation or trouble urinating may be increased


• Monoamine oxidase inhibitors (MAOIs) (eg, phenelzine) because the risk of a severe reaction including fever, seizures, and coma may be increased


• Agonist/antagonist analgesics (eg, pentazocine) or naltrexone because they may decrease Opana ER Extended-Release Tablets's effectiveness and withdrawal may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Opana ER Extended-Release Tablets may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Opana ER Extended-Release Tablets:

Use Opana ER Extended-Release Tablets as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Take Opana ER Extended-Release Tablets on an empty stomach at least 1 hour before or 2 hours after eating.


• Opana ER Extended-Release Tablets must only be taken by mouth.


• Swallow Opana ER Extended-Release Tablets whole. Do not break, crush, dissolve, or chew the tablet.


• If you are taking Opana ER Extended-Release Tablets for persistent pain, take it on a regular schedule to help control the pain more effectively.


• Do not change your dose or suddenly stop taking Opana ER Extended-Release Tablets without checking with your doctor.


• If Opana ER Extended-Release Tablets are no longer needed, dispose of it as soon as possible. Ask your doctor or pharmacist how to dispose of Opana ER Extended-Release Tablets properly.


• If you miss a dose of Opana ER Extended-Release Tablets and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Opana ER Extended-Release Tablets.

Important safety information:

• Opana ER Extended-Release Tablets may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol, other opiate pain medicines, or certain other medicines. Use Opana ER Extended-Release Tablets with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do not drink alcohol, take medicines that contain alcohol, or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you take Opana ER Extended-Release Tablets; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.


• Opana ER Extended-Release Tablets may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.


• Opana ER Extended-Release Tablets may be habit forming. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Misuse or abuse of Opana ER Extended-Release Tablets may cause severe side effects, including severe breathing problems, seizures, coma, and possibly death.


• Constipation is a common side effect of Opana ER Extended-Release Tablets. Talk to your doctor about using laxatives or stool softeners to prevent or treat constipation while you use Opana ER Extended-Release Tablets.


• If your pain continues or becomes worse or if you have side effects that concern you, contact your doctor.


• Tell your doctor or dentist that you take Opana ER Extended-Release Tablets before you receive any medical or dental care, emergency care, or surgery.


• Use Opana ER Extended-Release Tablets with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness, dizziness, confusion, and nausea.


• Opana ER Extended-Release Tablets should be used with extreme caution in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Opana ER Extended-Release Tablets may cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Opana ER Extended-Release Tablets while you are pregnant. It is unknown if Opana ER Extended-Release Tablets are found in breast milk. Do not breast-feed while taking Opana ER Extended-Release Tablets.

When used for long periods of time or at high doses, Opana ER Extended-Release Tablets may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Opana ER Extended-Release Tablets stops working well. Do not take more than prescribed.

Some people who use Opana ER Extended-Release Tablets for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Opana ER Extended-Release Tablets regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Opana ER Extended-Release Tablets are suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Opana ER Extended-Release Tablets.

Possible side effects of Opana ER Extended-Release Tablets:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Anxiety; constipation; decreased appetite; dizziness; drowsiness; dry mouth; gas; headache; lightheadedness; nausea; sweating; vomiting.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; fainting; fast, slow, or irregular heartbeat; fever; hallucinations; mental or mood changes; seizure; severe or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed, or difficult breathing; trouble urinating; unusual swelling; vision changes.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Opana ER side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; limp muscles; numbness of an arm or leg; pinpoint pupils; severe drowsiness or dizziness; slow or irregular heartbeat.

Proper storage of Opana ER Extended-Release Tablets:

Store Opana ER Extended-Release Tablets at 77 degrees F (25 degrees C). Store away from heat, moisture, and light. Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Do not store Opana ER Extended-Release Tablets in the bathroom. Keep Opana ER Extended-Release Tablets out of the reach of children and away from pets.

General information:

• If you have any questions about Opana ER Extended-Release Tablets, please talk with your doctor, pharmacist, or other health care provider.


• Opana ER Extended-Release Tablets are to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Opana ER Extended-Release Tablets. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Opana ER resources

• Opana ER Side Effects (in more detail)
• Opana ER Use in Pregnancy & Breastfeeding
• Drug Images
• Opana ER Drug Interactions
• Opana ER Support Group
• 43 Reviews for Opana ER - Add your own review/rating

Compare Opana ER with other medications

• Pain

Baytet

Generic Name: tetanus immune globulin (Intramuscular route)

TET-a-nus i-MUNE GLOB-ue-lin

Commonly used brand name(s)

In the U.S.

• Baytet


• HyperTET S/D

Available Dosage Forms:

• Solution

Therapeutic Class: Immune Serum

Uses For Baytet

Tetanus immune globulin is used to prevent tetanus infection (also known as lockjaw). Tetanus is a serious illness that causes convulsions (seizures) and severe muscle spasms that can be strong enough to cause bone fractures of the spine. Tetanus causes death in 30 to 40 percent of cases.

In recent years, two thirds of all tetanus cases have been in persons 50 years of age and older. A tetanus infection in the past does not make you immune to tetanus in the future.

Tetanus immune globulin works by giving your body the antibodies it needs to protect it against tetanus infection. This is called passive protection. This passive protection lasts long enough to protect your body until your body can produce its own antibodies against tetanus.

Tetanus immune globulin is to be administered only by or under the supervision of your doctor or other health care professional.

Before Using Baytet

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Although there is no specific information comparing use of tetanus immune globulin in children with use in other age groups, this medicine is not expected to cause different side effects or problems in children than it does in adults.

Geriatric

Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of tetanus immune globulin in the elderly with use in other age groups. However, there is no evidence that the effects of tetanus immune globulin in older adults differ from those in younger persons.

Pregnancy

	Pregnancy Category	Explanation
All Trimesters	C	Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding

Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.

Interactions with Medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with Food/Tobacco/Alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Other Medical Problems

The presence of other medical problems may affect the use of tetanus immune globulin. Make sure you tell your doctor if you have any other medical problems.

Proper Use of tetanus immune globulin

This section provides information on the proper use of a number of products that contain tetanus immune globulin. It may not be specific to Baytet. Please read with care.

Dosing

The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.

The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.

• For injection dosage form:
  
  • For preventing tetanus infection:
    
    • Adults and children—250 units injected into a muscle.
    
    
  
  

Baytet Side Effects

Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur:

Rare

• Difficulty in breathing or swallowing


• hives


• itching, especially of soles or palms


• reddening of skin, especially around ears


• swelling of eyes, face, or inside of nose


• unusual tiredness or weakness, sudden and severe

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Baytet side effects (in more detail)

The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.

The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.

More Baytet resources

• Baytet Side Effects (in more detail)
• Baytet Use in Pregnancy & Breastfeeding
• Baytet Drug Interactions
• Baytet Support Group
• 0 Reviews for Baytet - Add your own review/rating

• HyperTET S/D Monograph (AHFS DI)


• Hypertet S/D Prescribing Information (FDA)

Compare Baytet with other medications

• Tetanus
• Tetanus Prophylaxis

Dewax

Dewax may be available in the countries listed below.

Ingredient matches for Dewax

Docusate

Docusate Sodium is reported as an ingredient of Dewax in the following countries:

• Bahrain


• Oman

International Drug Name Search

Andazol

Andazol may be available in the countries listed below.

Ingredient matches for Andazol

Albendazole

Albendazole is reported as an ingredient of Andazol in the following countries:

• Ethiopia


• Turkey

International Drug Name Search